Literature DB >> 30679802

Functional profiling of venetoclax sensitivity can predict clinical response in multiple myeloma.

Shannon M Matulis1, Vikas A Gupta1, Paola Neri2, Nizar J Bahlis2, Paulo Maciag3, Joel D Leverson3, Leonard T Heffner1, Sagar Lonial1, Ajay K Nooka1, Jonathan L Kaufman1, Lawrence H Boise4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30679802      PMCID： PMC6891824          DOI： 10.1038/s41375-018-0374-8

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  16 in total

1.  BCL2 dependency in diffuse large B-cell lymphoma: it's a family affair.

Authors:  Shannon M Matulis; Lawrence H Boise
Journal:  Haematologica       Date:  2020-08       Impact factor: 9.941

2.  Phase I Study of Venetoclax Plus Daratumumab and Dexamethasone, With or Without Bortezomib, in Patients With Relapsed or Refractory Multiple Myeloma With and Without t(11;14).

Authors:  Nizar J Bahlis; Rachid Baz; Simon J Harrison; Hang Quach; Shir-Jing Ho; Annette Juul Vangsted; Torben Plesner; Philippe Moreau; Simon D Gibbs; Sheryl Coppola; Xiaoqing Yang; Abdullah Al Masud; Jeremy A Ross; Orlando Bueno; Jonathan L Kaufman
Journal:  J Clin Oncol       Date:  2021-08-13       Impact factor: 44.544

3.  Chromatin Accessibility Identifies Regulatory Elements Predictive of Gene Expression and Disease Outcome in Multiple Myeloma.

Authors:  Paula M Vertino; Lawrence H Boise; Benjamin G Barwick; Vikas A Gupta; Shannon M Matulis; Jonathan C Patton; Doris R Powell; Yanyan Gu; David L Jaye; Karen N Conneely; Yin C Lin; Craig C Hofmeister; Ajay K Nooka; Jonathan J Keats; Sagar Lonial
Journal:  Clin Cancer Res       Date:  2021-03-17       Impact factor: 12.531

Review 4.  Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma.

Authors:  Benjamin G Barwick; Vikas A Gupta; Paula M Vertino; Lawrence H Boise
Journal:  Front Immunol       Date:  2019-05-21       Impact factor: 7.561

5.  High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple Myeloma.

Authors:  David G Coffey; Andrew J Cowan; Bret DeGraaff; Timothy J Martins; Niall Curley; Damian J Green; Edward N Libby; Rebecca Silbermann; Sylvia Chien; Jin Dai; Alicia Morales; Ted A Gooley; Edus H Warren; Pamela S Becker
Journal:  JCO Precis Oncol       Date:  2021-04-06

Review 6.  Programmed cell death, redox imbalance, and cancer therapeutics.

Authors:  Xiaofeng Dai; Danjun Wang; Jianying Zhang
Journal:  Apoptosis       Date:  2021-07-08       Impact factor: 4.677

7.  Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes.

Authors:  Carolane Seiller; Sophie Maiga; Cyrille Touzeau; Céline Bellanger; Charlotte Kervoëlen; Géraldine Descamps; Laurent Maillet; Philippe Moreau; Catherine Pellat-Deceunynck; Patricia Gomez-Bougie; Martine Amiot
Journal:  Cell Death Dis       Date:  2020-05-05       Impact factor: 8.469

8.  "Direct to Drug" screening as a precision medicine tool in multiple myeloma.

Authors:  Cecilia Bonolo de Campos; Nathalie Meurice; Joachim L Petit; Alysia N Polito; Yuan Xiao Zhu; Panwen Wang; Laura A Bruins; Xuewei Wang; Ilsel D Lopez Armenta; Susie A Darvish; Greg J Ahmann; Kimberly J Henderson; Shulan Tian; Jonas J Kruse; William M Stewart; Jeremy T Larsen; Craig B Reeder; David Dingli; Prashant Kapoor; Shaji K Kumar; Rafael Fonseca; P Leif Bergsagel; Esteban Braggio; A Keith Stewart
Journal:  Blood Cancer J       Date:  2020-05-11       Impact factor: 11.037

Review 9.  Restoring Apoptosis with BH3 Mimetics in Mature B-Cell Malignancies.

Authors:  Maxime Jullien; Patricia Gomez-Bougie; David Chiron; Cyrille Touzeau
Journal:  Cells       Date:  2020-03-14       Impact factor: 6.600

10.  Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma.

Authors:  Richa Bajpai; Aditi Sharma; Abhinav Achreja; Claudia L Edgar; Changyong Wei; Arusha A Siddiqa; Vikas A Gupta; Shannon M Matulis; Samuel K McBrayer; Anjali Mittal; Manali Rupji; Benjamin G Barwick; Sagar Lonial; Ajay K Nooka; Lawrence H Boise; Deepak Nagrath; Mala Shanmugam
Journal:  Nat Commun       Date:  2020-03-06       Impact factor: 14.919
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.